No Data
No Data
Express News | Junshi Biotech's A shares opened 13% higher, Junshi Biotech's H shares opened 14.5% higher, and the PD-1 monoclonal antibody was approved for listing by the US FDA.
Is Fidelity Advisor Biotechnology A (FBTAX) a Strong Mutual Fund Pick Right Now?
Hong Kong stocks change. H shares of Rongchang Biological Co., Ltd. rose by more than 12% at one point, reaching a three-month high.
On July 6, Gelong Exchange, Rongchang Biological H shares rose more than 12% at one point, and now hit a three-month high of 54.65 Hong Kong dollars. Rongchang Biological A shares rose about 7% to 56.09 yuan. At present, the company has approved two products to be listed in China, and launched the overseas clinical layout of the core varieties, initially showing the potential of transformation from biotechnology companies to pharmaceutical companies. Huatai expects the company's core varieties to continue to achieve milestones in 2022, including the overseas phase III clinical launch of potential SLE indications for Tetaximab and the overseas clinical launch of UC for vidiximab.
The market capitalization of A shares of medicine and biology breaks through the 8 trillion mark in 2021.
Original title: the market value of pharmaceutical biological A shares breaks through the 8 trillion mark in 2021 Pharmaceutical Daily | in 2021, the market capitalization of pharmaceutical biological A shares breaks through 8 trillion mark. Daily list of important information in the medical field, grasp the new trend of medicine, welcome to follow, excavate the cattle stock ~ Hequan Pharmaceutical Waigaoqiao Base smoothly passed the first preparation project, the United States FDA pre-listing inspection on January 4, 2022, Wuxi Apptec subsidiary Hequan Pharmaceutical Industry announced Its Waigaoqiao base in Shanghai hosted the preparation development and production of an innovative drug from FDA of the United States for its partners from October 22 to 26, 2021.
Express News | Anxu Biology: a total of 11700 winning numbers have been released.
Ginkgo Bioworks Announces Participation In Upcoming Virtual Conferences